An essential role for Src kinase in ErbB receptor signaling through the MAPK pathway

被引:47
作者
Olayioye, MA [1 ]
Badache, A [1 ]
Daly, JM [1 ]
Hynes, NE [1 ]
机构
[1] Friedrich Miescher Inst, CH-4002 Basel, Switzerland
关键词
receptor tyrosine kinase; nonreceptor protein tyrosine kinase; extracellular signal-regulated kinase; transcription; epidermal growth factor; neuregulin/heregulin; breast cancer;
D O I
10.1006/excr.2001.5242
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ErbB receptor tyrosine kinases are activated by multiple ligands such as epidermal growth factor (EGF) and neuregulins (NRGs), leading to stimulation of intracellular signaling pathways, including the mitogen-activated protein kinase (MAPK) cascade. We show here that Src kinase is essential for rapid EGF- and NRG-induced MAPK activation when the breast carcinoma cell lines T47D and SKBR3 are stimulated with low concentrations of ligand, In the presence of the pharmacological inhibitor CGP77675, which specifically blocks the activity of Src family kinases, ligand-induced MAPK activation was almost completely blocked at 5 min. Although this block was only transient, inactivation of Src suppressed ligand-induced transcription from a MAPK-responsive promoter. At the molecular level, the initial inhibition of MAPK by Src inactivation correlated with impaired ligand-induced Shc phosphorylation, Surprisingly, Src inhibition affected neither association of Shc with ErbB receptors nor phosphorylation of receptor-bound Shc. Thus, ErbB signaling requires the engagement of a novel Src-dependent route to MAPK, to trigger its rapid activation and subsequent efficient stimulation of transcription. (C) 2001 Academic Press.
引用
收藏
页码:81 / 87
页数:7
相关论文
共 37 条
[1]  
Badache A, 2001, CANCER RES, V61, P383
[2]  
Biscardi JS, 1999, ADV CANCER RES, V76, P61
[3]   Not all Shc's roads lead to Ras [J].
Bonfini, L ;
Migliaccio, E ;
Pelicci, G ;
Lanfrancone, L ;
Pelicci, P .
TRENDS IN BIOCHEMICAL SCIENCES, 1996, 21 (07) :257-261
[4]   Neuregulins and their receptors: A versatile signaling module in organogenesis and oncogenesis [J].
Burden, S ;
Yarden, Y .
NEURON, 1997, 18 (06) :847-855
[5]   An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB4 [J].
Chen, XM ;
Levkowitz, G ;
Tzahar, E ;
Karunagaran, D ;
Lavi, S ;
BenBaruch, N ;
Leitner, O ;
Ratzkin, BJ ;
Bacus, SS ;
Yarden, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (13) :7620-7629
[6]   NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways [J].
Daly, JM ;
Olayioye, MA ;
Wong, AML ;
Neve, R ;
Lane, HA ;
Maurer, FG ;
Hynes, NE .
ONCOGENE, 1999, 18 (23) :3440-3451
[7]   COMPARTMENTALIZATION OF SHC, GRB2 AND MSOS, AND HYPERPHOSPHORYLATION OF RAF-1 BY EGF BUT NOT INSULIN IN LIVER PARENCHYMA [J].
DIGUGLIELMO, GM ;
BAASS, PC ;
OU, WJ ;
POSNER, BI ;
BERGERON, JJM .
EMBO JOURNAL, 1994, 13 (18) :4269-4277
[8]   ONCOGENES, GROWTH-FACTORS, AND SIGNAL TRANSDUCTION [J].
FLIER, JS ;
DRUKER, BJ ;
MAMON, HJ ;
ROBERTS, TM .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (20) :1383-1391
[9]   ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling [J].
GrausPorta, D ;
Beerli, RR ;
Daly, JM ;
Hynes, NE .
EMBO JOURNAL, 1997, 16 (07) :1647-1655
[10]  
GRAUSPORTA D, 1995, MOL CELL BIOL, V15, P1182